nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—H1F0—ocular cancer	0.972	1	CbGaD
Risperidone—CYP2D6—Metabolism—GNA11—ocular cancer	7.41e-06	0.000263	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—E2F1—ocular cancer	7.32e-06	0.00026	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GNAQ—ocular cancer	7.31e-06	0.000259	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—E2F1—ocular cancer	7.21e-06	0.000255	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—E2F1—ocular cancer	7.19e-06	0.000255	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	7.14e-06	0.000253	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—E2F1—ocular cancer	7.06e-06	0.00025	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—AKT1—ocular cancer	6.97e-06	0.000247	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GNAQ—ocular cancer	6.89e-06	0.000244	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MDM2—ocular cancer	6.8e-06	0.000241	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MDM2—ocular cancer	6.76e-06	0.00024	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—ocular cancer	6.71e-06	0.000238	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MDM2—ocular cancer	6.62e-06	0.000235	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—E2F1—ocular cancer	6.56e-06	0.000232	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MDM2—ocular cancer	6.51e-06	0.000231	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—HRAS—ocular cancer	6.41e-06	0.000227	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HRAS—ocular cancer	6.32e-06	0.000224	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HRAS—ocular cancer	6.28e-06	0.000222	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MDM2—ocular cancer	6.22e-06	0.00022	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CDKN1B—ocular cancer	6.21e-06	0.00022	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CDKN1B—ocular cancer	6.17e-06	0.000219	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HRAS—ocular cancer	6.15e-06	0.000218	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—AKT1—ocular cancer	6.14e-06	0.000218	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—AKT1—ocular cancer	6.1e-06	0.000216	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HRAS—ocular cancer	6.05e-06	0.000214	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CDKN1B—ocular cancer	6.04e-06	0.000214	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—AKT1—ocular cancer	5.98e-06	0.000212	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CDKN1B—ocular cancer	5.95e-06	0.000211	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCND1—ocular cancer	5.93e-06	0.00021	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCND1—ocular cancer	5.89e-06	0.000209	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—AKT1—ocular cancer	5.88e-06	0.000208	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MDM2—ocular cancer	5.86e-06	0.000208	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MDM2—ocular cancer	5.78e-06	0.000205	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HRAS—ocular cancer	5.77e-06	0.000205	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCND1—ocular cancer	5.76e-06	0.000204	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CDKN1A—ocular cancer	5.73e-06	0.000203	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CDKN1A—ocular cancer	5.69e-06	0.000202	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	5.68e-06	0.000201	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCND1—ocular cancer	5.67e-06	0.000201	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—AKT1—ocular cancer	5.66e-06	0.000201	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	5.61e-06	0.000199	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—AKT1—ocular cancer	5.58e-06	0.000198	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CDKN1A—ocular cancer	5.58e-06	0.000198	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—AKT1—ocular cancer	5.54e-06	0.000196	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CDKN1A—ocular cancer	5.49e-06	0.000194	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EP300—ocular cancer	5.45e-06	0.000193	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HRAS—ocular cancer	5.45e-06	0.000193	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—AKT1—ocular cancer	5.43e-06	0.000192	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EP300—ocular cancer	5.42e-06	0.000192	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCND1—ocular cancer	5.41e-06	0.000192	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HRAS—ocular cancer	5.37e-06	0.00019	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CDKN1B—ocular cancer	5.35e-06	0.00019	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—AKT1—ocular cancer	5.34e-06	0.000189	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EP300—ocular cancer	5.31e-06	0.000188	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—AKT1—ocular cancer	5.29e-06	0.000188	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CDKN1B—ocular cancer	5.28e-06	0.000187	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	5.24e-06	0.000186	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—AKT1—ocular cancer	5.22e-06	0.000185	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MDM2—ocular cancer	5.22e-06	0.000185	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EP300—ocular cancer	5.22e-06	0.000185	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCND1—ocular cancer	5.11e-06	0.000181	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—AKT1—ocular cancer	5.1e-06	0.000181	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MDM2—ocular cancer	5.04e-06	0.000179	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCND1—ocular cancer	5.04e-06	0.000179	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MDM2—ocular cancer	5.01e-06	0.000178	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EP300—ocular cancer	4.98e-06	0.000177	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CDKN1A—ocular cancer	4.94e-06	0.000175	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MDM2—ocular cancer	4.88e-06	0.000173	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CDKN1A—ocular cancer	4.87e-06	0.000173	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	4.85e-06	0.000172	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNA11—ocular cancer	4.84e-06	0.000172	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—EP300—ocular cancer	4.82e-06	0.000171	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—ocular cancer	4.81e-06	0.00017	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MDM2—ocular cancer	4.8e-06	0.00017	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	4.77e-06	0.000169	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—ocular cancer	4.75e-06	0.000168	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—ocular cancer	4.74e-06	0.000168	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—ocular cancer	4.74e-06	0.000168	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—ocular cancer	4.72e-06	0.000167	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	4.72e-06	0.000167	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—ocular cancer	4.71e-06	0.000167	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EP300—ocular cancer	4.7e-06	0.000167	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HRAS—ocular cancer	4.68e-06	0.000166	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—EP300—ocular cancer	4.68e-06	0.000166	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HRAS—ocular cancer	4.66e-06	0.000165	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EP300—ocular cancer	4.64e-06	0.000164	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—ocular cancer	4.62e-06	0.000164	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—ocular cancer	4.61e-06	0.000163	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	4.6e-06	0.000163	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	4.58e-06	0.000162	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	4.55e-06	0.000161	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—ocular cancer	4.55e-06	0.000161	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—ocular cancer	4.55e-06	0.000161	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—ocular cancer	4.54e-06	0.000161	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	4.53e-06	0.000161	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	4.53e-06	0.000161	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNAQ—ocular cancer	4.5e-06	0.00016	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	4.46e-06	0.000158	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	4.45e-06	0.000158	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MDM2—ocular cancer	4.43e-06	0.000157	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	4.41e-06	0.000156	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	4.4e-06	0.000156	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—ocular cancer	4.39e-06	0.000156	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	4.38e-06	0.000155	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—ocular cancer	4.37e-06	0.000155	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MDM2—ocular cancer	4.35e-06	0.000154	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MDM2—ocular cancer	4.35e-06	0.000154	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—ocular cancer	4.34e-06	0.000154	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	4.34e-06	0.000154	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—ocular cancer	4.33e-06	0.000154	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	4.28e-06	0.000152	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MDM2—ocular cancer	4.26e-06	0.000151	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—ocular cancer	4.25e-06	0.000151	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	4.25e-06	0.000151	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	4.23e-06	0.00015	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—ocular cancer	4.19e-06	0.000148	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—ocular cancer	4.18e-06	0.000148	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—ocular cancer	4.13e-06	0.000147	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—ocular cancer	4.11e-06	0.000146	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—ocular cancer	4.11e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	4.11e-06	0.000146	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—ocular cancer	4.1e-06	0.000145	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—ocular cancer	4.09e-06	0.000145	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—ocular cancer	4.05e-06	0.000143	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	4.05e-06	0.000143	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—ocular cancer	4.04e-06	0.000143	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—ocular cancer	4.04e-06	0.000143	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1B—ocular cancer	4.04e-06	0.000143	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—ocular cancer	4.04e-06	0.000143	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—ocular cancer	4.03e-06	0.000143	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—ocular cancer	4.02e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	4e-06	0.000142	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—ocular cancer	4e-06	0.000142	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	3.98e-06	0.000141	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1B—ocular cancer	3.97e-06	0.000141	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MDM2—ocular cancer	3.96e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	3.96e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	3.94e-06	0.00014	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	3.93e-06	0.000139	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—ocular cancer	3.92e-06	0.000139	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—ocular cancer	3.91e-06	0.000139	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—ocular cancer	3.9e-06	0.000138	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	3.89e-06	0.000138	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—ocular cancer	3.88e-06	0.000137	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—ocular cancer	3.86e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	3.85e-06	0.000136	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—ocular cancer	3.85e-06	0.000136	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—ocular cancer	3.8e-06	0.000135	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—ocular cancer	3.8e-06	0.000135	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—ocular cancer	3.79e-06	0.000134	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—ocular cancer	3.79e-06	0.000134	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—ocular cancer	3.74e-06	0.000132	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—ocular cancer	3.73e-06	0.000132	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1A—ocular cancer	3.73e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—ocular cancer	3.71e-06	0.000132	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—ocular cancer	3.71e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	3.68e-06	0.00013	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	3.67e-06	0.00013	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1A—ocular cancer	3.66e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—ocular cancer	3.65e-06	0.000129	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	3.64e-06	0.000129	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—ocular cancer	3.63e-06	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—ocular cancer	3.63e-06	0.000129	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	3.62e-06	0.000128	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	3.59e-06	0.000127	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	3.58e-06	0.000127	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—ocular cancer	3.57e-06	0.000127	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—ocular cancer	3.57e-06	0.000127	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—ocular cancer	3.57e-06	0.000126	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—ocular cancer	3.56e-06	0.000126	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—ocular cancer	3.55e-06	0.000126	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—ocular cancer	3.52e-06	0.000125	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—ocular cancer	3.51e-06	0.000125	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—ocular cancer	3.5e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	3.5e-06	0.000124	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—ocular cancer	3.5e-06	0.000124	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—ocular cancer	3.49e-06	0.000124	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—ocular cancer	3.48e-06	0.000123	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—ocular cancer	3.48e-06	0.000123	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—ocular cancer	3.45e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—ocular cancer	3.42e-06	0.000121	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—ocular cancer	3.41e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—ocular cancer	3.41e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	3.4e-06	0.00012	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—ocular cancer	3.36e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—ocular cancer	3.35e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	3.35e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	3.34e-06	0.000118	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—ocular cancer	3.32e-06	0.000118	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—ocular cancer	3.3e-06	0.000117	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—ocular cancer	3.27e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	3.25e-06	0.000115	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—ocular cancer	3.22e-06	0.000114	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—ocular cancer	3.21e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—ocular cancer	3.18e-06	0.000113	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—ocular cancer	3.17e-06	0.000112	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—ocular cancer	3.15e-06	0.000112	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—ocular cancer	3.09e-06	0.00011	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—ocular cancer	3.08e-06	0.000109	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—ocular cancer	3.04e-06	0.000108	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—ocular cancer	3.04e-06	0.000108	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—ocular cancer	3.04e-06	0.000108	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—ocular cancer	3.03e-06	0.000107	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—ocular cancer	3.01e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—ocular cancer	3e-06	0.000106	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—ocular cancer	2.98e-06	0.000106	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	2.97e-06	0.000105	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—ocular cancer	2.91e-06	0.000103	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—ocular cancer	2.89e-06	0.000103	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—ocular cancer	2.88e-06	0.000102	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—ocular cancer	2.87e-06	0.000102	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—ocular cancer	2.84e-06	0.000101	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—ocular cancer	2.83e-06	0.0001	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—ocular cancer	2.8e-06	9.93e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—ocular cancer	2.8e-06	9.92e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—ocular cancer	2.77e-06	9.81e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—ocular cancer	2.77e-06	9.8e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	2.76e-06	9.79e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—ocular cancer	2.75e-06	9.76e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—ocular cancer	2.75e-06	9.75e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—ocular cancer	2.68e-06	9.49e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—ocular cancer	2.63e-06	9.34e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—ocular cancer	2.63e-06	9.31e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—ocular cancer	2.54e-06	9e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—ocular cancer	2.53e-06	8.97e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—ocular cancer	2.5e-06	8.86e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—ocular cancer	2.49e-06	8.84e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—ocular cancer	2.48e-06	8.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—ocular cancer	2.45e-06	8.67e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—ocular cancer	2.44e-06	8.66e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—ocular cancer	2.43e-06	8.61e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—ocular cancer	2.43e-06	8.61e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—ocular cancer	2.39e-06	8.47e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—ocular cancer	2.38e-06	8.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—ocular cancer	2.36e-06	8.38e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—ocular cancer	2.34e-06	8.29e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—ocular cancer	2.33e-06	8.24e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—ocular cancer	2.3e-06	8.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—ocular cancer	2.27e-06	8.06e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—ocular cancer	2.17e-06	7.7e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—ocular cancer	2.14e-06	7.6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—ocular cancer	2.11e-06	7.48e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—ocular cancer	2.11e-06	7.46e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—ocular cancer	2.1e-06	7.46e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—ocular cancer	2.07e-06	7.32e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—ocular cancer	1.92e-06	6.8e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—ocular cancer	1.62e-06	5.74e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—ocular cancer	1.59e-06	5.63e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—ocular cancer	1.5e-06	5.3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—ocular cancer	9.78e-07	3.47e-05	CbGpPWpGaD
